Jim Longley

Outcomes4Me Inc., a health technology company using artificial intelligence to support cancer care, has appointed Jim Longley as Chief Revenue Officer. 

Longley joins the company from OpenEvidence, where he most recently served as Senior Vice President of AI Partnerships.

In his new role, Longley will lead Outcomes4Me’s revenue organization and support the company’s growth strategy, including the expansion of collaborations across the life sciences sector. He brings more than two decades of leadership experience spanning healthcare technology, commercial strategy, business development, and AI partnerships.

Before joining Outcomes4Me, Longley spent nearly five years at GoodRx, progressing through senior commercial leadership roles and ultimately serving as Senior Vice President and Head of Commercial. Earlier, he spent more than six years at Doximity as Vice President of Business Development and Product Innovation.

Longley’s appointment follows several recent developments for Outcomes4Me. The company was named to the Inc. 5000 list of fastest-growing private companies for the second consecutive year after reporting 395% three-year growth. Outcomes4Me Founder and CEO Dr. Maya R. Said was also recognized on the 2026 Fierce50 list by Fierce Pharma, Fierce Biotech, and Fierce Healthcare.

The company was additionally nominated for “Best Startup” in the Prix Galien USA program. Its clinical team recently integrated 10 National Comprehensive Cancer Network (NCCN) updates into the Outcomes4Me platform, covering several cancer types.

Outcomes4Me’s poster on patient-reported outcomes and disparities in breast cancer was also selected for a spotlight session at the 2026 San Antonio Breast Cancer Symposium.